메뉴 건너뛰기




Volumn 9, Issue 1, 2005, Pages 4-6

Chronic daily headache in the absence of medication overuse: Is daily or continuous pain more treatment-resistant than chronic daily headache with pain-free days?

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ERGOT ALKALOID; FLUOXETINE; FREE RADICAL; IRON; PLACEBO; TIZANIDINE;

EID: 14044260000     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-005-0067-7     Document Type: Note
Times cited : (10)

References (10)
  • 2
    • 1442265540 scopus 로고    scopus 로고
    • International Headache Society edn 2. Cephalalgia
    • International Headache Society: The international Classification of Headache Disorders, edn 2. Cephalalgia 2004, 24(suppl 1):9-160.
    • (2004) The International Classification of Headache Disorders , vol.24 , Issue.SUPPL. 1 , pp. 9-160
  • 3
    • 1642633811 scopus 로고    scopus 로고
    • Chronic daily headache and the revised International Headache Society classification
    • Levin M: Chronic daily headache and the revised International Headache Society classification. Curr Pain Headache Rep 2004, 8:59-65.
    • (2004) Curr. Pain Headache Rep. , vol.8 , pp. 59-65
    • Levin, M.1
  • 4
    • 0019408893 scopus 로고
    • Cognitive behavioral treatment of chronic headache
    • Bakal DA, Demjen S, Kaganov JA: Cognitive behavioral treatment of chronic headache. Headache 1981, 21:81-86.
    • (1981) Headache , vol.21 , pp. 81-86
    • Bakal, D.A.1    Demjen, S.2    Kaganov, J.A.3
  • 5
    • 0027944865 scopus 로고
    • Double-blind trial of fluoxetine: Chronic daily headache and migraine
    • Saper JR, Silberstein SD, Lake AE 3rd, Winters ME: Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994, 34:497-502.
    • (1994) Headache , vol.34 , pp. 497-502
    • Saper, J.R.1    Silberstein, S.D.2    Lake III, A.E.3    Winters, M.E.4
  • 6
    • 0036617410 scopus 로고    scopus 로고
    • Chronic daily headache prophylaxis with tizanidine: A double-blind, placebo-controlled, multicenter outcome study
    • Saper JR, Lake AE 3rd, Cantrell DT, et al.: Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache 2002, 42:470-482.
    • (2002) Headache , vol.42 , pp. 470-482
    • Saper, J.R.1    Lake III, A.E.2    Cantrell, D.T.3
  • 7
    • 14044252436 scopus 로고    scopus 로고
    • Chronic migraine with daily pain is more treatment resistant than chronic migraine with non-daily pain
    • Lake AE 3rd, Saper JR: Chronic migraine with daily pain is more treatment resistant than chronic migraine with non-daily pain. Headache 2003, 43:573.
    • (2003) Headache , vol.43 , pp. 573
    • Lake III, A.E.1    Saper, J.R.2
  • 8
    • 0035029439 scopus 로고    scopus 로고
    • An open-label, dose-titration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache
    • Saper JR, Winner PK, Lake AE 3rd: An open-label, dose-titration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache. Headache 2001, 41:357-368.
    • (2001) Headache , vol.41 , pp. 357-368
    • Saper, J.R.1    Winner, P.K.2    Lake III, A.E.3
  • 9
    • 1542365240 scopus 로고    scopus 로고
    • Migraine as a risk factor for subclinical brain lesions
    • Kruit MC, van Buchem MA, Holman PA, et al.: Migraine as a risk factor for subclinical brain lesions. JAMA 2004, 291:427-434.
    • (2004) JAMA , vol.291 , pp. 427-434
    • Kruit, M.C.1    van Buchem, M.A.2    Holman, P.A.3
  • 10
    • 0034883824 scopus 로고    scopus 로고
    • Periaqueductal gray matter dysfunction in migraine: Cause or the burden of illness?
    • Welch KM, Cao Y, Aurora S, et al.: Periaqueductal gray matter dysfunction in migraine: Cause or the burden of illness? Headache 2001, 41:629-637.
    • (2001) Headache , vol.41 , pp. 629-637
    • Welch, K.M.1    Cao, Y.2    Aurora, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.